At a glance
- Originator Nonindustrial source
- Class Pyridones; Vascular disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 29 Apr 2002 Discontinued - Preclinical for Cancer in Canada (unspecified route)
- 29 Apr 2002 No development reported - Preclinical for Cancer in USA (unspecified route)
- 30 Jul 1997 New profile